Press Releases Archives - Page 80 of 103 - Lupin

BSE 2324.25 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2324.25 NSE 2324.50

Lupin launches Generic Niaspan® Tablets in the US

Lupin Receives FDA Approval for Generic Monodox® Capsules and Cipro® for Oral Suspension

Lupin Receives FDA Approval for Generic Mycobutin® Capsules

February 26, 2014

Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy

February 18, 2014

Strong Growth, Record Profits Quarter III Results, FY 2013-14 Net Sales up 21%; EBITDA up 28%; Net profit up 42% Declares Interim Dividend of 150 %

February 3, 2014

Lupin Receives FDA Approval for Generic Mycobutin® Capsules

February 3, 2014

Lupin launches Generic Trizivir® Tablets

December 18, 2013

Lupin launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg strengths in the US

December 12, 2013

Lupin Receives FDA Approval for Generic Trizivir® Tablets

December 10, 2013

Lupin launches Generic Trilipix® Delayed-Release Capsules 45 mg & 135 mg in the US

December 6, 2013

1 2 … 79 80 81 … 102 103

Search

Hit enter to search or ESC to close